2.335
0.035 (1.52%)
0.035 (1.52%)
Upgrade to Real-Time
Regular Market
Low
0.82
High
5.98
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Infinity Pharmaceuticals Inc | INFI | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.035 | 1.52% | 2.335 | 13:45:27 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.28 | 2.18 | 2.44 | 2.30 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 2.33 | 2.34 | 0.01 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 8,105 | 3,012,848 | $ 2.34 | $ 7,037,586 | - | 0.82 - 5.98 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:45:36 | 4 | $ 2.335 | USD |
Period:
Draw Mode:
Infinity Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 206.99M | 88.65M | 86.73M | $ 1.72M | $ - | -0.68 | -3.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 166.12k | 3.80% |
Infinity Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical INFI Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.54 | 2.77 | 2.18 | 2.53 | 2,175,187 | -0.205 | -8.07% |
| 1 Month | 3.05 | 3.26 | 2.18 | 2.78 | 2,160,613 | -0.715 | -23.44% |
| 3 Months | 3.37 | 3.72 | 2.18 | 3.00 | 1,990,456 | -1.04 | -30.71% |
| 6 Months | 4.00 | 5.98 | 2.18 | 3.56 | 2,831,461 | -1.67 | -41.63% |
| 1 Year | 0.8376 | 5.98 | 0.82 | 3.23 | 1,866,713 | 1.50 | 178.77% |
| 3 Years | 1.75 | 5.98 | 0.60 | 2.84 | 796,095 | 0.585 | 33.43% |
| 5 Years | 1.56 | 5.98 | 0.60 | 2.56 | 858,785 | 0.775 | 49.68% |
Infinity Pharmaceuticals Description
| Infinity Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel medicines for the treatment of specific cancers. The company's developed products and those under development include therapies targeting hematologic malignancies, or blood cancers; refractory indolent non-Hodgkin lymphoma; refractory chronic lymphocytic leukemia; and solid tumors, including melanoma and non-small cell lung cancer. Infinity has a strategic partnership with AbbVie to develop some of its oncology-related treatments. The company operates in only one segment which is drug development. |
